Edwin J. Ostrin

3.8k total citations
53 papers, 2.3k citations indexed

About

Edwin J. Ostrin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Edwin J. Ostrin has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Edwin J. Ostrin's work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (12 papers) and RNA modifications and cancer (8 papers). Edwin J. Ostrin is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (12 papers) and RNA modifications and cancer (8 papers). Edwin J. Ostrin collaborates with scholars based in United States, Japan and Mexico. Edwin J. Ostrin's co-authors include Samir Hanash, Hiroyuki Katayama, Peiling Tsou, Graeme Mardon, Johannes F. Fahrmann, Jichao Chen, Benjamin J. Frankfort, Rashmi S. Hegde, Chandramohan Kattamuri and Ignacio I. Wistuba and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Edwin J. Ostrin

47 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin J. Ostrin United States 24 1.3k 586 586 559 447 53 2.3k
Juana García-Pedrero Spain 31 1.4k 1.1× 346 0.6× 847 1.4× 395 0.7× 552 1.2× 111 2.7k
Florian Bassermann Germany 26 1.7k 1.4× 334 0.6× 789 1.3× 334 0.6× 217 0.5× 105 2.9k
Andrew C. Hsieh United States 23 2.6k 2.1× 423 0.7× 568 1.0× 271 0.5× 553 1.2× 70 3.6k
Luc Furic Australia 28 2.4k 1.9× 328 0.6× 341 0.6× 257 0.5× 465 1.0× 48 3.0k
Hosein Kouros‐Mehr United States 21 1.8k 1.4× 572 1.0× 1.3k 2.2× 194 0.3× 532 1.2× 35 2.9k
Malek Faham United States 27 1.5k 1.2× 316 0.5× 1.2k 2.0× 706 1.3× 748 1.7× 92 4.2k
Udayan Guha United States 24 1.0k 0.8× 471 0.8× 679 1.2× 118 0.2× 227 0.5× 51 2.1k
Michael Zeschnigk Germany 30 2.2k 1.7× 162 0.3× 708 1.2× 525 0.9× 294 0.7× 72 3.3k
Mamoru Ouchida Japan 38 2.7k 2.1× 1.1k 2.0× 1.1k 1.9× 331 0.6× 792 1.8× 108 4.3k
Wayne Yu United States 26 2.2k 1.8× 231 0.4× 431 0.7× 178 0.3× 431 1.0× 41 3.0k

Countries citing papers authored by Edwin J. Ostrin

Since Specialization
Citations

This map shows the geographic impact of Edwin J. Ostrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin J. Ostrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin J. Ostrin more than expected).

Fields of papers citing papers by Edwin J. Ostrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin J. Ostrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin J. Ostrin. The network helps show where Edwin J. Ostrin may publish in the future.

Co-authorship network of co-authors of Edwin J. Ostrin

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin J. Ostrin. A scholar is included among the top collaborators of Edwin J. Ostrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin J. Ostrin. Edwin J. Ostrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ostrin, Edwin J., Jianjun Zhang, Jia Wu, et al.. (2025). Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status. International Journal of Cancer. 157(5). 941–953.
2.
Chen, Yihui, So‐Young Park, Jody V. Vykoukal, et al.. (2025). Citrullinated ENO1 Vaccine Enhances PD-1 Blockade in Mice Implanted with Murine Triple-Negative Breast Cancer Cells. Vaccines. 13(6). 629–629.
3.
Irajizad, Ehsan, James P. Long, Johannes F. Fahrmann, et al.. (2025). Impact of Comorbidities on the Mortality Benefits of Lung Cancer Screening: A Post-Hoc Analysis of the PLCO and NLST Trials. Journal of Thoracic Oncology. 20(5). 565–576. 3 indexed citations
4.
Vachani, Anil, Luis Seijó, Gorka Bastarrika, et al.. (2025). AI-assisted Lung Cancer Screening: Results From REALITY, A Pivotal Validation Study of an AI/ML-based Algorithm. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5223–A5223. 1 indexed citations
5.
Tai, Mei-Chee, Leonidas E. Bantis, Ichidai Tanaka, et al.. (2024). Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. International Journal of Molecular Sciences. 25(4). 2331–2331.
6.
Niu, Jiangong, Fengyi Jin, Kelly W. Merriman, et al.. (2024). Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening. Cancer Medicine. 13(5). e7069–e7069. 6 indexed citations
7.
Chen, Yihui, Ranran Wu, Ehsan Irajizad, et al.. (2023). Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor Prognosis. Cancers. 15(3). 834–834. 18 indexed citations
8.
Irajizad, Ehsan, Johannes F. Fahrmann, Tracey L. Marsh, et al.. (2023). Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. Journal of Clinical Oncology. 41(27). 4360–4368. 10 indexed citations
9.
Yuan, Bo, Qian Peng, Yewen Shi, et al.. (2022). Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer. JCI Insight. 7(11). 43 indexed citations
10.
Fahrmann, Johannes F., Tracey L. Marsh, Ehsan Irajizad, et al.. (2022). Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. Journal of Clinical Oncology. 40(8). 876–883. 57 indexed citations
11.
Vykoukal, Jody V., Johannes F. Fahrmann, Nikul Patel, et al.. (2022). Contributions of Circulating microRNAs for Early Detection of Lung Cancer. Cancers. 14(17). 4221–4221. 21 indexed citations
12.
Fahrmann, Johannes F., Hiroyuki Katayama, Ehsan Irajizad, et al.. (2021). Plasma Based Protein Signatures Associated with Small Cell Lung Cancer. Cancers. 13(16). 3972–3972. 6 indexed citations
13.
Fahrmann, Johannes F., Xiangying Mao, Ehsan Irajizad, et al.. (2020). Plasma-Derived Extracellular Vesicles Convey Protein Signatures That Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas. Cancers. 12(5). 1147–1147. 20 indexed citations
14.
Deng, Shanshan, Yiping Dong, Mauricio S. Caetano, et al.. (2020). Interplay between estrogen and Stat3/NF-κB-driven immunomodulation in lung cancer. Carcinogenesis. 41(11). 1529–1542. 13 indexed citations
15.
Khosravi, Nasim, Mauricio S. Caetano, Amber M. Cumpian, et al.. (2018). IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties. Cancer Immunology Research. 6(7). 788–797. 49 indexed citations
16.
Tripathi, S. C., Johannes F. Fahrmann, Müge Çeliktaş, et al.. (2017). MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway. Cancer Research. 77(16). 4414–4425. 85 indexed citations
17.
Caetano, Mauricio S., Huiyuan Zhang, Amber M. Cumpian, et al.. (2016). IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras–Mutant Lung Cancer. Cancer Research. 76(11). 3189–3199. 169 indexed citations
18.
Tripathi, S. C., Haley L. Peters, Ayumu Taguchi, et al.. (2016). Loss of immunoproteasome driven by EMT is associated with immune evasion and poor prognosis in non-small cell lung cancer. Journal of Thoracic Oncology. 11(2). S48–S49. 1 indexed citations
19.
Solberg, Owen D., Edwin J. Ostrin, Michael I. Love, et al.. (2012). Airway Epithelial miRNA Expression Is Altered in Asthma. American Journal of Respiratory and Critical Care Medicine. 186(10). 965–974. 199 indexed citations
20.
Ostrin, Edwin J., et al.. (2004). Structure–function analysis of the Drosophila retinal determination protein Dachshund. Developmental Biology. 272(1). 231–247. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juana García-Pedrero Breakdown of academic impact, for papers by Florian Bassermann Breakdown of academic impact, for papers by Andrew C. Hsieh Breakdown of academic impact, for papers by Luc Furic Breakdown of academic impact, for papers by Hosein Kouros‐Mehr Breakdown of academic impact, for papers by Malek Faham Breakdown of academic impact, for papers by Udayan Guha Breakdown of academic impact, for papers by Michael Zeschnigk Breakdown of academic impact, for papers by Mamoru Ouchida Breakdown of academic impact, for papers by Wayne Yu
Rankless by CCL
2026